Sumalee Obchoei

447 total citations
20 papers, 350 citations indexed

About

Sumalee Obchoei is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Sumalee Obchoei has authored 20 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Surgery and 6 papers in Oncology. Recurrent topics in Sumalee Obchoei's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Mechanisms and Therapy (4 papers) and Signaling Pathways in Disease (4 papers). Sumalee Obchoei is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer Mechanisms and Therapy (4 papers) and Signaling Pathways in Disease (4 papers). Sumalee Obchoei collaborates with scholars based in Thailand, Japan and United States. Sumalee Obchoei's co-authors include Chaisiri Wongkham, Qizhi Yao, Changyi Chen, Sopit Wongkham, Kanlayanee Sawanyawisuth, Min Li, Kenji Nakano, Lin Cui, Kiyoko Setoguchi and Tsuyoshi Yamamoto and has published in prestigious journals such as Gastroenterology, PLoS ONE and Life Sciences.

In The Last Decade

Sumalee Obchoei

18 papers receiving 348 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumalee Obchoei Thailand 9 273 100 96 60 57 20 350
Xiaofei Cao China 11 315 1.2× 173 1.7× 60 0.6× 64 1.1× 27 0.5× 25 411
Wachiko Nakata Japan 9 251 0.9× 77 0.8× 130 1.4× 105 1.8× 91 1.6× 10 436
Tanner J. Freeman United States 8 238 0.9× 95 0.9× 136 1.4× 69 1.1× 30 0.5× 13 446
Zhijiu Zhong United States 6 196 0.7× 95 0.9× 126 1.3× 63 1.1× 34 0.6× 9 349
Sheren Al-Obaidi Australia 7 190 0.7× 39 0.4× 89 0.9× 49 0.8× 20 0.4× 8 268
Shruthi Sriramkumar United States 8 191 0.7× 103 1.0× 103 1.1× 70 1.2× 18 0.3× 10 352
Jinglue Song China 10 243 0.9× 95 0.9× 97 1.0× 55 0.9× 23 0.4× 16 411
Martyna Pakuła Poland 10 143 0.5× 57 0.6× 91 0.9× 45 0.8× 22 0.4× 15 289
Liane Jurida Germany 7 232 0.8× 129 1.3× 102 1.1× 109 1.8× 19 0.3× 10 417
Pin Dong Li China 10 278 1.0× 172 1.7× 133 1.4× 78 1.3× 19 0.3× 11 404

Countries citing papers authored by Sumalee Obchoei

Since Specialization
Citations

This map shows the geographic impact of Sumalee Obchoei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumalee Obchoei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumalee Obchoei more than expected).

Fields of papers citing papers by Sumalee Obchoei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumalee Obchoei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumalee Obchoei. The network helps show where Sumalee Obchoei may publish in the future.

Co-authorship network of co-authors of Sumalee Obchoei

This figure shows the co-authorship network connecting the top 25 collaborators of Sumalee Obchoei. A scholar is included among the top collaborators of Sumalee Obchoei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumalee Obchoei. Sumalee Obchoei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roytrakul, Sittiruk, et al.. (2024). Proteomics and Bioinformatics Identify Drug-Resistant-Related Genes with Prognostic Potential in Cholangiocarcinoma. Biomolecules. 14(8). 969–969. 3 indexed citations
3.
Kaewdech, Apichat, Hutcha Sriplung, Chanon Kongkamol, et al.. (2024). Impact of Clinical Characteristics and Treatment on Cholangiocarcinoma Prognosis in Southern Thailand. Cancer Medicine. 13(24). e70491–e70491.
4.
Roytrakul, Sittiruk, et al.. (2024). Knockdown of cullin 3 inhibits progressive phenotypes and increases chemosensitivity in cholangiocarcinoma cells. Molecular Medicine Reports. 30(5). 1 indexed citations
5.
Runsaeng, Phanthipha, et al.. (2023). Two Recombinant Bacteriocins, Rhamnosin and Lysostaphin, Show Synergistic Anticancer Activity Against Gemcitabine-Resistant Cholangiocarcinoma Cell Lines. Probiotics and Antimicrobial Proteins. 16(3). 713–725. 4 indexed citations
6.
Saengboonmee, Charupong, Sumalee Obchoei, Kanlayanee Sawanyawisuth, & Sopit Wongkham. (2023). Revision of potential prognostic markers of cholangiocarcinoma for clinical practice. Expert Review of Anticancer Therapy. 23(5). 517–530. 3 indexed citations
7.
Kotepui, Kwuntida Uthaisar, Sumalee Obchoei, Kulthida Vaeteewoottacharn, et al.. (2022). Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma. Asian Pacific Journal of Cancer Prevention. 23(2). 715–721. 2 indexed citations
8.
Obchoei, Sumalee, et al.. (2022). Determination of the efficacy of using a serine protease gene as a DNA vaccine to protect against Vibrio parahaemolyticus infection in Litopenaeus vannamei. Developmental & Comparative Immunology. 135. 104459–104459. 5 indexed citations
9.
Obchoei, Sumalee, et al.. (2022). Low Dose Berberine Suppresses Cholangiocarcinoma Cell Progression as a Multi-Kinase Inhibitor. Asian Pacific Journal of Cancer Prevention. 23(10). 3379–3386. 4 indexed citations
10.
11.
Dana, Paweena, Ryusho Kariya, Seiji Okada, et al.. (2019). CD147 augmented monocarboxylate transporter-1/4 expression through modulation of the Akt-FoxO3-NF-κB pathway promotes cholangiocarcinoma migration and invasion. Cellular Oncology. 43(2). 211–222. 18 indexed citations
13.
Setoguchi, Kiyoko, Lin Cui, Sumalee Obchoei, et al.. (2017). Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes. Molecular Therapy — Nucleic Acids. 9. 170–181. 31 indexed citations
14.
Vaeteewoottacharn, Kulthida, Wunchana Seubwai, Chutima Talabnin, et al.. (2016). Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity. Oncology Reports. 36(3). 1435–1446. 27 indexed citations
15.
Obchoei, Sumalee, Rungnapha Saeeng, Chaisiri Wongkham, & Sopit Wongkham. (2016). Novel Synthetic Mono-triazole Glycosides Induce G0/G1 Cell-cycle Arrest and Apoptosis in Cholangiocarcinoma Cells. Anticancer Research. 36(11). 5965–5974. 4 indexed citations
16.
Obchoei, Sumalee, Kanlayanee Sawanyawisuth, Chaisiri Wongkham, et al.. (2014). Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway. Tumor Biology. 36(2). 849–859. 2 indexed citations
17.
Sawanyawisuth, Kanlayanee, Chaisiri Wongkham, Kulthida Vaeteewoottacharn, et al.. (2013). Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma. BMC Cancer. 13(1). 430–430. 20 indexed citations
18.
Obchoei, Sumalee, et al.. (2012). Overexpression of claudin-4 in cholangiocarcinoma tissues and its possible role in tumor metastasis.. PubMed. 13 Suppl. 71–6. 12 indexed citations
19.
Obchoei, Sumalee, Sarah M. Weakley, Sopit Wongkham, et al.. (2011). Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma. Molecular Cancer. 10(1). 102–102. 53 indexed citations
20.
Obchoei, Sumalee, et al.. (2009). Cyclophilin A: potential functions and therapeutic target for human cancer.. PubMed. 15(11). RA221–32. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026